Literature DB >> 656452

Bile acid pool changes and regulation of cholate synthesis in experimental diabetes.

F O Nervi, C H Severín, V D Valdivieso.   

Abstract

The effect of alloxan-diabetes and insulin treatment in bile acid pool size and composition, bile acid secretion and cholic acid synthesis was investigated in the rat. The size of the cholate pool was significantly increased 4 days after diabetes induction. It reached a constant size three times that of control animals after 2 weeks of diabetes. Changes in bile acid pool size and secretion were directly dependent of the insulin deficiency state since they were reversed by insulin treatment and were not influenced by the caloric intake of the animal nor the pharmacologic effect of alloxan. Biliary cholate secretion was also 3-fold increased in diabetic rats and it accounted for more than 80% of the total bile acids compared to 60% in the control group. The calculated daily rate of cholate synthesis was increased in diabetic rats and the circadian rhythm of cholate synthesis was abolished in this condition. Therefore, it was shown that the negative feedback mechanism that regulates bile acid snythesis was deleted in diabetes. This mechanism was partially restored after 2 weeks of insulin treatment. These studies demonstrated that bile acid metabolism was profoundly changed in alloxan-diabetic rats and suggested that insulin may play an important role in the regulation of bile acid snythesis and intestinal absorption.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656452     DOI: 10.1016/0005-2760(78)90064-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Identification and characterization of cis-acting elements conferring insulin responsiveness on hamster cholesterol 7alpha-hydroxylase gene promoter.

Authors:  E De Fabiani; M Crestani; M Marrapodi; A Pinelli; V Golfieri; G Galli
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

2.  Plasma metabolomic profile in nonalcoholic fatty liver disease.

Authors:  Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

Review 3.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

4.  Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis.

Authors:  Xuemei Ge; Liya Yin; Huiyan Ma; Tiangang Li; John Y L Chiang; Yanqiao Zhang
Journal:  J Lipid Res       Date:  2011-06-05       Impact factor: 5.922

5.  High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.

Authors:  Svetlana Golocorbin-Kon; Jelena Calasan; Boris Milijasevic; Sasa Vukmirovic; Mladena Lalic-Popovic; Momir Mikov; Hani Al-Salami
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

Review 6.  Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.

Authors:  Bart Staels; Vivian A Fonseca
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

7.  Increased biliary cholesterol secretion in alloxan diabetic mice.

Authors:  Y Ishikawa; K Uchida; T Akiyoshi
Journal:  Jpn J Surg       Date:  1984-03

8.  Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes.

Authors:  Bingning Dong; Mohammed Qatanani; David D Moore
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

Review 9.  Bile acids, obesity, and the metabolic syndrome.

Authors:  Huijuan Ma; Mary Elizabeth Patti
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-07-11       Impact factor: 3.043

10.  Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms.

Authors:  Leila Valanejad; Mwlod Ghareeb; Stephanie Shiffka; Christina Nadolny; Yuan Chen; Liangran Guo; Ruchi Verma; Sangmin You; Fatemeh Akhlaghi; Ruitang Deng
Journal:  Mol Cell Endocrinol       Date:  2017-10-09       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.